← Leaderboards
Y. Lynn Wang
University Of Pennsylvania
$1,129,368
Attributed
$1,129,368
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $262.3K · FY2005–22$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,129,368 · 2
By mechanism
K08$652,914 · 1
R21$476,454 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Stephen G Emerson$28,932,839
- Jerry D Glickson$20,468,757
- Mary Beth Leonard$17,530,683
- Charles H Vite$11,840,835
- Luca Busino$6,731,473
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisCell LineLymphomaPeroxisome Proliferator Activated ReceptorLeukocyte Activation /TransformationTissue /Cell CultureS LymphomaLaboratory MouseBcl2 Gene /ProteinCellular RespirationCell DeathOxidative PhosphorylationMicroarray TechnologyCell Growth RegulationLymphatic TissueLipid MetabolismHematopoietic Stem CellsGlucose MetabolismGene ExpressionCell DivisionBehaviorChronic Lymphocytic LeukemiaCell BehaviorBase
Grant awards (7)
Building clinically faithful ex vivo indolent lymphoma models for personalized therapy$214,186
R21 · FY2022 · CA · contact PI
Building clinically faithful ex vivo indolent lymphoma models for personalized therapy$262,268
R21 · FY2021 · CA · contact PI
Role of PPARy in Lymphocyte Survival and Transformation$130,680
K08 · FY2006 · HL · contact PI
Role of PPARy in Lymphocyte Survival and Transformation$130,680
K08 · FY2005 · HL
Role of PPARy in Lymphocyte Survival and Transformation$130,680
K08 · FY2004 · HL
Role of PPARy in Lymphocyte Survival and Transformation$130,680
K08 · FY2003 · HL
Role of PPARy in Lymphocyte Survival and Transformation$130,194
K08 · FY2002 · HL